Latest Commercialization News

Eden Innovations attributes recent share price rise to an upcoming US defence forum presentation, confirming no undisclosed material information.

Motio Ltd has marked a turning point with its first net profit, record sales activity, and a 13% increase in forward revenue, signaling a shift to scalable growth.

SKS Technologies has landed a $22 million contract to deliver integrated electrical systems for a major retailer's new Melbourne headquarters, pushing its order book to $355 million amid a booming project pipeline.

Chatham Rock Phosphate has secured a definitive financing agreement with Wetstone Global that doubles an existing loan to USD 300,000 and converts it into a 30% equity stake, granting Wetstone majority board control and potential for up to 70% ownership upon project milestones.

ADX Energy’s HOCH-1 well has been deepened to 1619 metres, revealing six new thin gas sand intervals below the primary Hall Formation target. Wireline logging scheduled for 8 May will verify reservoir quality and gas saturation, with production testing to follow if results confirm the discovery’s potential.

Norwest Minerals reports strong metallurgical results from Bulgera, with gold recoveries up to 92% on coarse crushed samples, supporting a low-cost heap leach development pathway.

Australian Unity Office Fund has called an extraordinary meeting to secure approval for selling its final property, delisting from the ASX, and winding up the fund, with directors unanimously recommending the proposal.

Murray Cod Australia (ASX:MCA) has launched the retail tranche of its fully underwritten $18.6 million entitlement offer at a 43% discount, aiming to convert its record 3,700-tonne biomass into cash and expand processing capacity.

Swift TV has gained final Netflix approval after a multi-year certification, becoming Australia’s sole enterprise Connective TV platform with direct Google Play Store access. This integration bolsters its foothold in sectors demanding seamless consumer streaming with robust enterprise controls.

REA Group delivered robust Q3 FY26 results, driven by double-digit revenue growth in Australia and record engagement on realestate.com.au, while lowering its cost growth guidance for FY26.

Vectus Biosystems appoints Dr Tara Speranza as CEO and CTO to accelerate development of lead fibrosis drug VB0004 with performance-linked incentives.

Amaero Ltd is set to re-domicile from Australia to Delaware via court-approved schemes, issuing US HoldCo CHESS Depositary Interests to shareholders while maintaining its ASX listing. The move aims to tap into deeper US capital markets and enhance strategic growth opportunities.